BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 7790854)

  • 1. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
    Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
    J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.
    Mazei MS; Pluto CP; Kirkbride B; Pehek EA
    Brain Res; 2002 May; 936(1-2):58-67. PubMed ID: 11988230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
    Gálosi R; Petykó Z; Kállai V; Tóth A; Ollmann T; Péczely L; Kovács A; Berta B; Lénárd L
    Behav Brain Res; 2018 May; 344():57-64. PubMed ID: 29454007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
    Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
    J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat.
    Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
    J Neurochem; 1994 Aug; 63(2):575-83. PubMed ID: 8035182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
    Kawahara H; Kawahara Y; Westerink BH
    Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Longu G; Pira L; Gessa GL
    Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
    Bongiovanni R; Newbould E; Jaskiw GE
    Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.
    Devoto P; Flore G; Vacca G; Pira L; Arca A; Casu MA; Pani L; Gessa GL
    Psychopharmacology (Berl); 2003 Apr; 167(1):79-84. PubMed ID: 12632247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
    Page ME; Lucki I
    Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of extracellular dopamine by the norepinephrine transporter.
    Yamamoto BK; Novotney S
    J Neurochem; 1998 Jul; 71(1):274-80. PubMed ID: 9648875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
    Clinton SM; Sucharski IL; Finlay JM
    Psychopharmacology (Berl); 2006 Jan; 183(4):404-12. PubMed ID: 16307295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.
    Devoto P; Flore G; Saba P; Frau R; Gessa GL
    Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine.
    Boyce PJ; Finlay JM
    Brain Res Bull; 2009 Apr; 79(2):104-110. PubMed ID: 19320060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.